Pointe Capital Management LLC Bristol Myers Squibb CO Transaction History

Pointe Capital Management LLC

  • $160 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$65.71 - $74.53 $188,719 - $214,050
2,872 New
2,872 $199,000
Q1 2018

May 10, 2018
SELL
$59.92 - $68.98 $256,337 - $295,096
-4,278 Closed
0 $0
Q3 2017

Oct 16, 2017
BUY
$55.23 - $63.74 $236,273 - $272,679
4,278
4,278 $273,000

Others Institutions Holding BMY

# of Institutions
2,428
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Pointe Capital Management LLC Portfolio

Follow Pointe Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pointe Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pointe Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email